hsg logo white

HD InsightsMeet the Company

Approved Raptor Logo with (R) -04042014

 

 

 

 

VITAL SIGNS

NAME: Raptor Pharmaceuticals

HEADQUARTERS: Novato, CA

STOCK PRICE AS OF 10/15/2014: $10.19

52 WEEK RANGE: $7.12-$17.72

MARKET CAPITALIZATION: $639 million

EMPLOYEES: ~125

APPROVED COMPOUNDS: Cysteamine bitartrate delayed-release capsules (PROCYSBI®), FDA- approved in 2013 for treatment of nephropathic cystinosis in adults and children age 6 and older.

About HD Insights

Our mission is to promote, disseminate, and facilitate research on Huntington’s disease. To fulfill this mission, we are guided by an outstanding editorial board that includes representatives from three continents, academia, industry, and the HD community.